BGNE - BeiGene gains as access to leukemia drug Brukinsa expands
2024-03-13 11:57:58 ET
More on BeiGene
- BeiGene Still Bleeding Red Ink Despite Blockbuster Drug
- BeiGene: Debating On Finally Establishing A Position
- BeiGene gets FDA accelerated approval for Brukinsa for follicular lymphoma
- FDA accepts BeiGene license application for gastric cancer combo therapy
- Seeking Alpha’s Quant Rating on BeiGene